Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis

  • Technology appraisal guidance
  • TA708
  • Published: 
Download guidance (PDF)

2 Information about budesonide orodispersible tablet

Marketing authorisation indication

2.1 Budesonide orodispersible tablet (Jorveza, Dr Falk Pharma UK) is indicated for the treatment of eosinophilic esophagitis in adults.

Dosage in the marketing authorisation

2.2 The dosage schedule is available in the summary of product characteristics.

Price

2.3 The list price is £323 per pack of 90 one‑mg tablets (excluding VAT; BNF online, accessed April 2021). Costs may vary in different settings because of negotiated procurement discounts.